EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+29.65%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.58B
AUM Growth
+$264M
(+20%)
Cap. Flow
-$55.8M
Cap. Flow
% of AUM
-3.54%
Top 10 Holdings %
Top 10 Hldgs %
70.28%
Holding
330
New
38
Increased
107
Reduced
155
Closed
24
Top Buys
| 1 |
JOYY
JOYY Inc. American Depositary Shares
JOYY
|
$3.5M |
| 2 |
Weibo
WB
|
$2.6M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$1.88M |
| 4 |
Deckers Outdoor
DECK
|
$1.72M |
| 5 |
Invesco QQQ Trust
QQQ
|
$1.55M |
Top Sells
| 1 |
STAAR Surgical
STAA
|
$20.3M |
| 2 |
Yum China
YUMC
|
$12.8M |
| 3 |
Pinduoduo
PDD
|
$10.6M |
| 4 |
TSMC
TSM
|
$9.64M |
| 5 |
Apple
AAPL
|
$4.98M |
Sector Composition
| 1 | Consumer Discretionary | 50.26% |
| 2 | Technology | 23.48% |
| 3 | Communication Services | 8.85% |
| 4 | Real Estate | 5.2% |
| 5 | Healthcare | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Vaxcyte
PCVX
$4.29B
| $532K | 0.03% |
8,476
+60
| +0.7% | +$3.77K |
|
152
Sarepta Therapeutics
SRPT
$1.96B
| $532K | 0.03% |
5,519
+1,705
| +45% | +$164K |
|
153
Exelixis
EXEL
$10.2B
| $524K | 0.03% |
21,832
+1,150
| +6% | +$27.6K |
|
154
TG Therapeutics
TGTX
$5.11B
| $522K | 0.03% |
30,553
-13,457
| -31% | -$230K |
|
155
Natera
NTRA
$23.1B
| $517K | 0.03% |
8,260
-177
| -2% | -$11.1K |
|
156
Immunovant
IMVT
$2.99B
| $516K | 0.03% |
12,256
-2,989
| -20% | -$126K |
|
157
Alkermes
ALKS
$4.94B
| $515K | 0.03% |
18,573
+2,723
| +17% | +$75.5K |
|
158
CDW
CDW
$22.2B
| $514K | 0.03% |
2,262
+1,044
| +86% | +$237K |
|
159
PACCAR
PCAR
$52B
| $512K | 0.03% |
5,244
-505
| -9% | -$49.3K |
|
160
GE HealthCare
GEHC
$34.6B
| $507K | 0.03% |
6,556
+294
| +5% | +$22.7K |
|
161
Intellia Therapeutics
NTLA
$1.29B
| $505K | 0.03% |
16,551
+4,476
| +37% | +$136K |
|
162
Arista Networks
ANET
$180B
| $502K | 0.03% |
8,524
-584
| -6% | -$34.4K |
|
163
Carnival Corp
CCL
$42.8B
| $501K | 0.03% |
+27,038
| New | +$501K |
|
164
PTC Therapeutics
PTCT
$4.55B
| $501K | 0.03% |
18,188
+7,589
| +72% | +$209K |
|
165
Amphenol
APH
$135B
| $501K | 0.03% |
10,100
-732
| -7% | -$36.3K |
|
166
Nuvalent
NUVL
$5.83B
| $500K | 0.03% |
6,798
+1,883
| +38% | +$139K |
|
167
CrowdStrike
CRWD
$105B
| $500K | 0.03% |
1,959
-174
| -8% | -$44.4K |
|
|
MRTX
168
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $500K | 0.03% |
8,503
-4,320
| -34% | -$254K |
|
169
Ionis Pharmaceuticals
IONS
$9.76B
| $499K | 0.03% |
9,865
-1,231
| -11% | -$62.3K |
|
170
BioMarin Pharmaceuticals
BMRN
$11.1B
| $498K | 0.03% |
5,168
+98
| +2% | +$9.45K |
|
171
Beam Therapeutics
BEAM
$2.11B
| $495K | 0.03% |
18,174
+704
| +4% | +$19.2K |
|
|
IMGN
172
DELISTED
Immunogen Inc
IMGN
| $488K | 0.03% |
16,443
-12,682
| -44% | -$376K |
|
173
Ross Stores
ROST
$49.4B
| $470K | 0.03% |
3,394
-355
| -9% | -$49.1K |
|
174
Syndax Pharmaceuticals
SNDX
$1.47B
| $466K | 0.03% |
21,580
+6,986
| +48% | +$151K |
|
175
Copart
CPRT
$47B
| $465K | 0.03% |
9,494
-855
| -8% | -$41.9K |
|